RKDA

#5169
Arcadia Biosciences, Inc. - Common Stock
0.9 8 USD
+2.08%
Sektor: Konjunkturunabhängige Konsumgüter
Basis: USD
Gewinnwährung: USD
Tagesspanne
0.92
0.98
Jahresspanne
0.81
6.71
Tagesänderung
+2.08%
Monatliche Änderung
-3.92%
6 month change
-72.63%
Jahresänderung
-79.71%
Vorheriger Schlusskurs
0.9 6
Open
0.9 5
Tief
0.9 2
High
0.9 8
Volumen
14
Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
  • Market Capitalization 2.02 M
  • Employee 8
  • Founded 2002
  • CEO N/A
  • Website www.arcadiabio.com
  • Headquarter Delaware, United States
  • FIGI BBG000GYBX66
  • Industry Verpackte Produkte
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
-1.16
Preis-Umsatz-Verhältnis
0.53

Arcadia Biosciences, Inc. - Common Stock

Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation. It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.

Nachrichten